Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EV/EBIT

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year EV/EBIT History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/EBIT(x) 47.7027.698.479.606.50

What is the latest EV/EBIT ratio of GLENMARK PHARMACEUTICALS ?

The latest EV/EBIT ratio of GLENMARK PHARMACEUTICALS is 47.70 based on Mar2024 Consolidated results.
Year EV/EBIT
Mar202447.70
Mar202327.69
Mar20228.47
Mar20219.60
Mar20206.50

How is EV/EBIT of GLENMARK PHARMACEUTICALS Trending?

Years EV/EBIT % Change
Mar2024 47.7
72.26
Mar2023 27.69
226.92
Mar2022 8.47
-11.77
Mar2021 9.6
47.69
Mar2020 6.5 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EV/EBIT ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹62,734.5 Cr 0.2% 35.6% 57.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,267.0 Cr 0.7% 2.8% 7.9% Stock Analytics
DIVIS LABORATORIES ₹178,672.0 Cr -0.8% 3.7% 48.6% Stock Analytics
CIPLA ₹119,713.0 Cr -0.2% -0.1% -1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,195.0 Cr 3.4% 11.2% 17.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,999.0 Cr 0.6% -5.2% -4.9% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

0.2%

35.6%

57.9%

SENSEX

-0.9%

0.4%

1.4%


You may also like the below Video Courses